Has Steven Laster, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,252 in general payments to Steven Laster, MD across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Laster, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Laster, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Laster, MD

Interventional Cardiology · Kansas City, MONPI 1386601235

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Medtronic at 57.2% of the total. 2025 is the largest year on record at $1,727, 2.3 times the $757 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in MO, where the typical reported total is $10,448.

$6,252in general payments, 2019–2025

Across 77 payments — averaging $81.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$4K
Abbott$754
Boston Scientific$679
Recor Medical Inc$349
Shockwave Medical, Inc$256
Terumo Medical Corporation$153
plus $485 from 6 others

$564,277in research payments, 2019–2025

Across 104 payments — averaging $5425.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Shockwave Medical, Inc$401K
Recor Medical Inc$135K
Medtronic$18K
Boston Scientific$5K
Cardiovascular Systems Inc.$5K
Abbott$18

What the payments were for

Travel & lodging$4818%
Food & beverage$5,75292%
Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	44	$3,577
Abbott	8	$754
Boston Scientific	7	$679
Recor Medical Inc	5	$349
Shockwave Medical, Inc	3	$256
Terumo Medical Corporation	1	$153
Livanova USA, Inc.	2	$148
W. L. Gore & Associates, Inc.	2	$144
Siemens Medical Solutions USA, Inc.	2	$96
Angiodynamics, Inc.	1	$54
Edwards Lifesciences	1	$22
CSL Behring	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RESOLUTE ONYX$1,304
Telescope$290
JETi Peripheral Catheter$253
AVVIGO Guidance System$249
Resolute$203
ESPRIT$182
Paradise Ultrasound Renal Denervation System$166
JETI$156
Azur CX Detachable$153
Navicross$153
GlideWire$153
TandemLife$131
EXCLUDER Conformable AAA Endoprosthesis with Active Control$131
SYNERGY$120
GENERAL - THERAPIES$108
OPTIS$105

How this compares

$6,252 in reported general payments places this provider in the 35th percentile of 182 interventional cardiology providers in Missouri.

See all interventional cardiology providers in Missouri →

Medicare billing

Part B allowed, 2024

$136,428

Medicare patients

630

Services billed

1,446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	138	$175,794
Repatha SureclickEvolocumab	86	$71,404
XareltoRivaroxaban	58	$51,663
JardianceEmpagliflozin	18	$20,246
Praluent PenAlirocumab	19	$17,393
Ezetimibe	250	$6,281
Rosuvastatin Calcium	342	$5,895
Atorvastatin Calcium	510	$5,893
Metoprolol Succinate	262	$3,595
Ranolazine ErRanolazine	17	$2,269
Losartan Potassium	179	$2,013
ClopidogrelClopidogrel Bisulfate	211	$1,897
Cilostazol	67	$1,882
Carvedilol	211	$1,604
Isosorbide Mononitrate ErIsosorbide Mononitrate	82	$1,550

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Kansas City

Gerald MancusoKansas City$402K
James GranthamKansas City$357K
Matthew BunteKansas City$242K
Adnan ChhatriwallaKansas City$114K
Kenneth HuberKansas City$110K
Chetan HudedKansas City$61K
Adam SalisburyKansas City$52K
Steven MarsoKansas City$42K
Dany JacobKansas City$35K
Muhammad Anis HaiderKansas City$35K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →